Literature DB >> 11591758

Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo.

R Maldonado-López1, C Maliszewski, J Urbain, M Moser.   

Abstract

Prior studies have shown that subclasses of dendritic cells (DC) direct the development of distinct Th populations in rodents and in humans. In the mouse, we have recently shown that administration of Ag-pulsed CD8alpha(-) DC induces a Th2-type response, whereas injection of CD8alpha(+) DC leads to Th1 differentiation. To define the DC-derived factors involved in the polarization of Th responses, we injected either subset purified from mice genetically deficient for IFN-gamma, IL-4, IL-12, or IL-10 into wild-type animals. In this work, we report that DC-derived IL-12 and IFN-gamma are required for Th1 priming by CD8alpha(+) DC, whereas IL-10 is required for optimal development of Th2 cells by CD8alpha(-) DC. The level of IL-12 produced by the DC appears to determine the Th1/Th2 balance in vivo. We further show that the function of DC subsets displays some flexibility. Treatment of DC with IL-10 in vitro induces a selective decrease in the viability of CD8alpha(+) DC. Conversely, incubation with IFN-gamma down-regulates the Th2-promoting capacities of CD8alpha(-) DC and increases the Th1-skewing properties of both subsets.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591758     DOI: 10.4049/jimmunol.167.8.4345

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Reciprocal conditioning: T cells as regulators of dendritic cell function.

Authors:  Daniel M Altmann; Rosemary J Boyton
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

2.  Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile.

Authors:  Haitao Wen; Cory M Hogaboam; Jack Gauldie; Steven L Kunkel
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

3.  Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells.

Authors:  David Askew; Clifford V Harding
Journal:  Immunology       Date:  2007-10-19       Impact factor: 7.397

4.  Selective effect of burn injury on splenic CD11c(+) dendritic cells and CD8alpha(+)CD4(-)CD11c(+) dendritic cell subsets.

Authors:  Julie Patenaude; Michele D'Elia; Claudine Hamelin; Jacques Bernier
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

5.  Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection.

Authors:  Asher Maroof; Paul M Kaye
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

6.  GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis.

Authors:  Balaji B Ganesh; Donald M Cheatem; Jian Rong Sheng; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Int Immunol       Date:  2009-01-27       Impact factor: 4.823

Review 7.  Engineering better immunotherapies via RNA interference.

Authors:  Mouldy Sioud
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.

Authors:  Sayuri Yamazaki; Diana Dudziak; Gordon F Heidkamp; Christopher Fiorese; Anthony J Bonito; Kayo Inaba; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  CD8+ DC, but Not CD8(-)DC, isolated from BCG-infected mice reduces pathological reactions induced by mycobacterial challenge infection.

Authors:  Xiaoling Gao; Shuhe Wang; Yijun Fan; Hong Bai; Jie Yang; Xi Yang
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

10.  Hypogammaglobulinaemia secondary to cow-milk allergy in children under 2 years of age.

Authors:  Liliana Bezrodnik; Andrea C Gómez Raccio; Laura M Canil; Maria Amanda Rey; Patricia C Carabajal; Carlos A Fossati; Guillermo H Docena
Journal:  Immunology       Date:  2007-05-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.